Melanoma frequently harbors genetic alterations in key molecules leading to the aberrant activation of PI3K and its downstream pathways. Although the role of PI3K/AKT/mTOR in melanoma progression and drug resistance is well documented. targeting the PI3K/AKT/mTOR pathway showed less efficiency in clinical trials than might have been expected. since the suppression of the PI3K/mTOR sig... https://herbsdailyes.shop/product-category/medical-and-ambulatory-supplies-i-v-therapy/